California Atty. Gen. Rob Bonta said that Eli Lilly, Sanofi and Novo Nordisk are finding ways to “aggressively hike” the price of insulin at the expense of many patients.
California says it will sue the companies that make and promote much of the nation s insulin. Democratic Attorney General Rob Bonta announced the lawsuit Thursday. The lawsuit accuses insulin manufacturers
California's Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to “aggressively raise the list price of insulin in lockstep with each other to artificial levels.” Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products.
California is in the process of filing lawsuits against a group of pharmacy benefit managers and insulin manufacturers for using “unlawful, unfair, and deceptive” means to drive up costs.